Old Web
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease
2014
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
40
References
67
Citations
NaN
KQI